1.Role of mucosal mast cells in visceral hypersensitivity in a rat model of irritable bowel syndrome.
Jun Ho LA ; Tae Wan KIM ; Tae Sik SUNG ; Hyun Ju KIM ; Jeom Yong KIM ; Il Suk YANG
Journal of Veterinary Science 2004;5(4):319-324
The involvement of mucosal mast cells (MMC) in the pathophysiology of irritable bowel syndrome (IBS) is still controversial. We aimed to re-evaluate the role of MMC in visceral hypersensitivity associated with IBS using a rat IBS model that develops the IBS symptom after a subsidence of acetic acid-induced colitis. No significant difference in the number of MMC was observed between normal rat colon and IBS rat colon. (61.7 +/-2.9/mm 2 in normal vs. 88.7 +/-13.3/mm 2 in IBS, p >0.29). However, the degranulation rate of MMC was significantly higher in IBS rat colon (49.5 +/-2.4% in normal vs. 68.8 +/-3.4% in IBS, p >0.05). Pretreatment of a mast cell stabilizer, doxantrazole (5 mg/kg, i.p.), reduced the degranulation rate of MMC and significantly attenuated visceral hypersensitivity to rectal distension in IBS rat, whereas it had no effect on the visceral sensory responses in normal rat. These results suggest that, although the number of MMC is not significantly changed in IBS rat colon, the higher degranulation rate of MMC is responsible for visceral hypersensitivity in this model IBS.
Acetic Acid/toxicity
;
Animals
;
Cell Count
;
Colitis/chemically induced/*pathology
;
Hypersensitivity/*pathology
;
Image Processing, Computer-Assisted
;
Intestinal Mucosa/*pathology
;
Irritable Bowel Syndrome/*pathology
;
Male
;
Mast Cells/drug effects/*pathology
;
Models, Theoretical
;
Phosphodiesterase Inhibitors/pharmacology
;
Rats
;
Rats, Sprague-Dawley
;
Thioxanthenes/pharmacology
;
Viscera/immunology
;
Xanthones/pharmacology
2.A Case of Fetal Cardiac Tumor Diagnosed by Ultrasonography.
Sang Ki HONG ; Li La JUN ; Ho Jun LEE ; Kwang Seok KANG ; Kyeong A KIM
Korean Journal of Obstetrics and Gynecology 2002;45(5):900-904
Perinatal cardiac tumors are rare and the vast majority are histologically benign. Clinical manifestations depend on their size and location. Most of them are clinically unimportant but an arrhythmia or a cardiac failure may present as a feature of obstruction of the outflow tract. Cardiac rhabdomyoma is the most common type of the cardiac tumor and associated with the tuberous sclerosis, and may be the only sign of the tuberous sclerosis, especially, in fetus. We report a case of a cardiac tumor detected during routine prenatal ultrasonographic evaluation, which demonstrated features of rhabdomyoma. After birth, the newborn was diagnosed as tuberous sclerosis with brain MRI scanning.
Arrhythmias, Cardiac
;
Brain
;
Fetus
;
Heart Failure
;
Heart Neoplasms*
;
Humans
;
Infant, Newborn
;
Magnetic Resonance Imaging
;
Parturition
;
Rhabdomyoma
;
Tuberous Sclerosis
;
Ultrasonography*
3.Breast Cancer that was detected during Pregnancy.
Li La JUN ; Sang Ki HONG ; Su Kyoung BAEK ; Jong Yn OH ; Seung Sik SUH ; Yung Ho LE
Korean Journal of Obstetrics and Gynecology 2002;45(3):504-507
The pregnancy-associated breast cancer is one of the most common malignancy developed during pregnant period and occupies 1-2% of the all breast cancer patients. There is no evidence to implicate pregnancy or lactation in either the etiology and the progression of breast cancer. Careful breast examination early in the pregnancy is very important to find solid masses before breast engorgement hides them. But unfortunately, delay in the diagnosis is common and most of patients with operable primary lesions have positive axillary lymph nodes. The treatment of choice is the modified radical mastectomy and adjuvant chemotherapy. The authors report a patient of breast cancer diagnosed and treated during pregnancy with review of literature.
Breast Neoplasms*
;
Breast*
;
Chemotherapy, Adjuvant
;
Diagnosis
;
Female
;
Humans
;
Lactation
;
Lymph Nodes
;
Mastectomy, Modified Radical
;
Pregnancy*
4.Alteration of nitrergic neuromuscular transmission as a result of acute experimental colitis in rat.
Tae Sik SUNG ; Jun Ho LA ; Tae Wan KIM ; Il Suk YANG
Journal of Veterinary Science 2006;7(2):143-150
Nitric oxide (NO) is a non-adrenergic, non-cholinergic neurotransmitter found in the enteric nervous system that plays a role in a variety of enteropathies, including inflammatory bowel disease. Alteration of nitrergic neurons has been reported to be dependent on the manner by which inflammation is caused. However, this observed alteration has not been reported with acetic acid-induced colitis. Therefore, the purpose of the current study was to investigate changes in nitrergic neuromuscular transmission in experimental colitis in a rat model. Distal colitis was induced by intracolonic administration of 4% acetic acid in the rat. Animals were sacrificed at 4 h and 48 h postacetic acid treatment. Myeloperoxidase activity was significantly increased in the acetic acid-treated groups. However, the response to 60 mM KCl was not significantly different in the three groups studied. The amplitude of phasic contractions was increased by Nomega-nitro-L-arginine methyl ester (L-NAME) in the normal control group, but not in the acetic acid-treated groups. Spontaneous contractions disappeared during electrical field stimulation (EFS) in normal group. However, for the colitis groups, these contractions initially disappeared, and then reappeared during EFS. Moreover, the observed disappearance was diminished by L-NAME; this suggests that these responses were NO-mediated. In addition, the number of NADPH-diaphorase positive nerve cell bodies, in the myenteric plexus, was not altered in the distal colon; whereas the area of NADPH-diaphorase positive fibers, in the circular muscle layer, was decreased in the acetic acidtreated groups. These results suggest that NO-mediated inhibitory neural input, to the circular muscle, was decreased in the acetic acid-treated groups.
Acetic Acid/toxicity
;
Animals
;
Colitis/chemically induced/*pathology/*physiopathology
;
Colon/drug effects/enzymology/*innervation/pathology
;
Indicators and Reagents/toxicity
;
Male
;
Muscle Contraction/drug effects
;
Muscle, Smooth/drug effects/metabolism
;
Myenteric Plexus/pathology
;
NADPH Dehydrogenase/metabolism
;
NG-Nitroarginine Methyl Ester/pharmacology
;
Neuromuscular Junction/drug effects/*metabolism
;
Nitrergic Neurons/drug effects/*metabolism
;
Nitric Oxide/*metabolism
;
Peroxidase/metabolism
;
Potassium Chloride/pharmacology
;
Rats
;
Rats, Sprague-Dawley
5.Visceral Hypersensitivity and Altered Colonic Motility in Type 2 Diabetic Rat.
Tae Sik SUNG ; Jun Ho LA ; Tong Mook KANG ; Tae Wan KIM ; Il Suk YANG
Journal of Neurogastroenterology and Motility 2015;21(4):581-588
BACKGROUND/AIMS: Abnormal visceral sensitivity and disordered motility are common in patients with diabetes mellitus. The purpose of the present study was to investigate whether visceral sensation and bowel motility were altered in a rat model of type 2 diabetes mellitus accompanied by weight loss. METHODS: A type 2 diabetic rat model in adulthood was developed by administrating streptozotocin (STZ; 90 mg/kg, i.p.) to neonatal rats. Eight weeks after STZ administration, rats with blood glucose level of 200 mg/dL or higher were selected and used as diabetic group (n = 35) in this study. Abdominal withdrawal reflex and arterial pulse rate were measured to examine visceral nociception induced by colorectal distension (0.1-1.0 mL). The amplitude, frequency, and area under the curve (AUC) of spontaneous phasic contractions of colonic circular muscles were recorded in vitro to examine colonic motility. RESULTS: STZ-treated diabetic rats gained significantly less weight for 8 weeks than control (P < 0.01). Forty-eight percent of the diabetic rats showed enhanced visceral nociceptive response to colorectal distension. Diabetic rats did not differ from control rats in colorectal compliance. However, the frequency and AUC, not the amplitude, of colonic spontaneous contraction in vitro was significantly decreased in diabetic rats compared to control rats (P < 0.01 in frequency and P < 0.05 in AUC). CONCLUSIONS: These results demonstrate visceral hypersensitivity and colonic dysmotility in a rat model of type 2 diabetes mellitus accompanied by weight loss.
Animals
;
Area Under Curve
;
Blood Glucose
;
Colon*
;
Compliance
;
Diabetes Mellitus
;
Diabetes Mellitus, Type 2
;
Heart Rate
;
Humans
;
Hypersensitivity*
;
Models, Animal
;
Muscles
;
Nociception
;
Rats*
;
Reflex
;
Sensation
;
Streptozocin
;
Weight Loss
6.Hyperimmunoglobulin E-recurrent infection syndrome in a patient with juvenile dermatomyositis.
Jun Ki MIN ; Mi La CHO ; Seok Chan KIM ; Youn Soo LEE ; Sang Heon LEE ; Sung Hwan PARK ; Yeon Sik HONG ; Chul Soo CHO ; Ho Youn KIM
The Korean Journal of Internal Medicine 1999;14(1):95-98
A 13-year-old girl presented with multiple skin abscesses. She was diagnosed as having juvenile dermatomyositis (DM) at the age of 7 years. She had suffered from recurrent skin infections, atypical pruritic dermatitis and pneumonia since the age of 8 years. Bacteriologic and fungal cultures for skin abscesses and oral mucosa were positive S. aureus and C. albicans, respectively. Chemotactic defect in peripheral blood neutrophils was observed. The level of serum IgE was markedly elevated, and anti-S.aureus specific IgE was found. A diagnosis of hyperimmunoglobulin E-recurrent infection syndrome (HIE) was made and she was successfully treated with surgical drainage and antibiotics. To our knowledge, this is the first case report of HIE in a patient with juvenile dermatomyositis.
Adolescence
;
Case Report
;
Dermatomyositis/complications*
;
Female
;
Human
;
IgE/blood
;
Job's Syndrome/immunology
;
Job's Syndrome/diagnosis
;
Job's Syndrome/complications*
;
Staphylococcal Infections/immunology
;
Staphylococcal Infections/complications
;
Staphylococcus aureus/immunology
7.Effects of Hydroxychloroquine on the Metabolism of Fas ligand of T cells.
Jun Ki MIN ; Hee Jin LEE ; Won Sun LEE ; Sang Hee PARK ; So Youn MIN ; Mi La CHO ; Chul Soo CHO ; Ho Youn KIM
The Journal of the Korean Rheumatism Association 2000;7(2):127-139
OBJECTIVE: Hydroxychloroquine (HCQ) is a drug that has been used to treat autoimmune disorders such as rheumatoid arthritis and systemic lupus erythematosus. However, the specific mechanism for its pharmacologic action has been largely unknown. It has been reported that dysregulation of lymphocytic apoptosis mediated by Fas ligand (FasL) and Fas is associated with the development of autoimmune diseases and HCQ induces apoptosis in peripheral blood lymphocytes. These reports suggest that HCQ may exert its pharmacologic effects through the modulation of FasL and Fas. Therefore, we are intended to investigate the effects of HCQ on the regulation of FasL and Fas. Jurkat cells or peripheral blood mononuclear cells (PBMNC) were treated with varying concentrations of HCQ. Semiquantative reverse transcription- polymerase chain reaction, Western blotting, flow cytometry, and ELISA were used for this study. HCQ at nontoxic concentrations( 50~150 micrometer) caused a dose dependent increase of FasL mRNA expression and FasL in cell lysates. HCQ inhibited the release of intracellular 40 kDa FasL by Jurkat cells which were pulse-stimulated with PHA (50 microgram/ml). Jurkat cells activated with PHA increased membrane bound FasL (mFasL) expression (24.5+/-4.3%), however Jurkat cells pretreated with HCQ(150 micrometer) followed by PHA administration did not further increase mFasL expression (26.8+/-1.6%). Addition of different concentrations of HCQ to the cultured PBMNC stimulated with PHA for 24 hours showed increase of soluble FasL (sFasL). The levels of sFasL treated with HCQ zero, 50, 150 and 300 micrometer for 24 hours were 38.6+/-3.0, 43.4+/-5.1, 77.0+/-3.6(P<0.05) and 72.3+/-8.1pg/ml(P<0.05) respectively. However, fas metabolism was not affected by HCQ. CONCLUSION: These results suggest that HCQ may exhibit its pharmacological effects by upregulation of FasL gene expression and increased production sFasL without any influence on the Fas metabolism of T cells.
Apoptosis
;
Arthritis, Rheumatoid
;
Autoimmune Diseases
;
Blotting, Western
;
Enzyme-Linked Immunosorbent Assay
;
Fas Ligand Protein*
;
Flow Cytometry
;
Gene Expression
;
Humans
;
Hydroxychloroquine*
;
Jurkat Cells
;
Lupus Erythematosus, Systemic
;
Lymphocytes
;
Membranes
;
Metabolism*
;
Polymerase Chain Reaction
;
RNA, Messenger
;
T-Lymphocytes*
;
Up-Regulation
8.Electroacupuncture ameliorates experimental colitis induced by acetic acid in rat.
Jeoung Woo KANG ; Tae Wan KIM ; Jun Ho LA ; Tae Sik SUNG ; Hyun Ju KIM ; Young Bae KWON ; Jeum Yong KIM ; Il Suk YANG
Journal of Veterinary Science 2004;5(3):189-195
The effect of electroacupuncture (EA) on experimental colitis was investigated in Sprague-Dawley rats. Colitis was induced by intracolonic instillation of 4% acetic acid. EA (2 Hz, 0.05 ms, 2 V for 20min) was applied to bilateral Hoku (LI-4) and Zusanli (ST-36) on 12 hrs and 36 hrs after induction of colitis. EA-treatment significantly reduced the macroscopic damage and the myeloperoxidase activity of colonic samples at 3 days post-induction of colitis. Colitic colon showed a decreased in vitro motility. However, colonic motility of EAtreated group was not significantly different from that of normal group. The anti-inflammatory effect of EA was not inhibited by a glucocorticoid receptor antagonist, RU-486, but suppressed by a beta-adrenoceptor antagonist, propranonol. These results suggest that EA-treatment has a beneficial effect on colitis, and its anti-inflammatory effect is mediated by beta-adrenoceptor activation but not by endogenous glucocorticoiddependent mechanism.
Acetic Acid
;
Adrenergic beta-Antagonists/pharmacology
;
Animals
;
Carbachol/pharmacology
;
Cholinergic Agonists/pharmacology
;
Colitis/chemically induced/enzymology/pathology/*therapy
;
Electroacupuncture/*veterinary
;
Enzyme Inhibitors/metabolism
;
Gastrointestinal Motility/physiology
;
Hormone Antagonists/pharmacology
;
Male
;
Mifepristone/pharmacology
;
Muscle Contraction/physiology
;
Muscle, Smooth/drug effects/physiology
;
NG-Nitroarginine Methyl Ester/pharmacology
;
Peroxidase/metabolism
;
Propranolol/pharmacology
;
Rats
;
Rats, Sprague-Dawley
9.The Expression of G1-S Cell Cycle Inhibitors in Normal Placenta and Gestational Trophoblastic Diseases.
Yan Hua XUAN ; Kyung Hee KIM ; Yoon La CHOI ; Geung hwan AHN ; Seoung Wan CHAE ; Ho chang LEE ; Ok Jun LEE ; Seok Hyung KIM
Korean Journal of Pathology 2008;42(2):67-74
BACKGROUND: The objective of this study is to determine the expression pattern of G1-S inhibitor molecules in normal trophoblasts and gestational trophoblastic diseases, including hydatidiform moles and choriocarcinoma. METHODS: A total of 157 cases comprising 47 normal placentas and 110 gestational trophoblastic diseases such as choriocarcinoma (19 cases) and hydatidiform moles (91 cases of which 58 were complete, 12 were partial and 21 were invasive mole) were immunohistochemically analyzed on paraffin blocks using anti-p21, antip27, anti-p16, anti-p53, anti-pRb antibodies. RESULTS: The results revealed that in the normal placenta, all the G1-S cell cycle inhibitors were maximally expressed by the first-trimester trophoblasts and these levels decreased with gestational age. The expression of p21 and p53 was greatly enhanced in the gestational trophoblastic diseases, particularly in invasive mole and choriocarcinoma, whereas the p27 expression was significantly downregulated in choriocarcinoma. Especially, Rb expression was typically enhanced in the invasive mole, but not in choriocarcinoma. The expression level of p16 was low in all the cases, and particularly in choriocarcinoma. CONCLUSIONS: In conclusion, we demonstrated that the expression of G1/S cell cycle inhibitors correlates well with normal trophoblast differentiation, and these expressions are considerably altered in the gestational trophoblastic diseases, including complete/partial/ invasive hydatidiform mole and choriocarcinoma.
10.Polyostotic Fibrous Dysplasia Mimicking Multiple Bone Metastases in a Patient with Ductal Carcinoma In Situ.
Jun Ho LEE ; Sung Yong KIM ; Jeong Eon LEE ; Eun Yoon CHO ; Yoon La CHOI ; Joon Young CHOI ; Sun Wook HAN ; Seok Won KIM ; Won Ho KIL ; Seok Jin NAM
Journal of Breast Cancer 2014;17(1):83-87
Whole-body bone scans and whole body 18F-fluorodeoxyglucose positron emission tomographic/computed tomographic scans are sensitive for detecting bone metastasis in patients with breast cancer. However, it is often difficult to discriminate between bone metastasis and other nonmalignant bone lesions. Polyostotic fibrous dysplasia is a rare disorder characterized by the osteoid medullary cavity filling with fibrous tissue causing bony expansion. We report the case of a 42-year-old female patient with ductal carcinoma in situ, which appeared to have multiple bone metastases on initial work-up images. Subsequently, the bone metastases were identified as polyostotic fibrous dysplasia. The patient underwent modified radical mastectomy and subsequently visited for a second opinion regarding the bony metastases. She underwent right ilium computed tomography-guided biopsy. Pathology was consistent with fibrous dysplasia. This patient received only adjuvant tamoxifen, and 1.5 years later, there was no evidence of recurrence.
Adult
;
Biopsy
;
Breast Neoplasms
;
Carcinoma, Ductal*
;
Carcinoma, Intraductal, Noninfiltrating*
;
Electrons
;
Female
;
Fibrous Dysplasia of Bone
;
Fibrous Dysplasia, Polyostotic*
;
Humans
;
Ilium
;
Mastectomy, Modified Radical
;
Neoplasm Metastasis*
;
Pathology
;
Positron-Emission Tomography
;
Recurrence
;
Referral and Consultation
;
Tamoxifen
;
Whole Body Imaging